SenseLab 
logo Brain Pharmacology Database User: Public
Skip Navigation Links
  Go back
Pathological mechanism having Alzheimer as Pathology
 Name/ Notes
1
Abeta antagonizes alpha7 nAChR receptors; opposed by nicotine. 
  
2
Abeta blocks voltage-gated Na+ channels in GABA neurons causing abberant excitation 
  
4
Abeta decreases apical dendrite arborizations in cortical pyramidal cells in transgenic mice 
  
5
Abeta decreases dedritic spine number and alters dendritic spine morpholology 
  
6
Abeta decreases dendritic spine density and motility, increases spine legth. Rolipram blocks these e 
  
7
Abeta decreases dendritic spine number, causes dysmorphic spine shapes 
  
9
Abeta inhibits late LTP in animal models of Alzheimers 
  
10
Abeta inhibits LTP both in soluble and fibrillar conformational states 
  
11
Abeta inhibits LTP through TNFalpha 
  
12
Abeta inhibits nicotinic ACh receptors at pre-synaptic glutamatergic terminals  
  
14
Abeta modulates A current (HEK293 cells) 
  
17
Abeta peptides block LTP in rat CA1 in vivo 
  
18
Abeta-derived diffusible ligands (ADDLs) attack synapses at or near NMDA receptors 
  
19
Abeta42/Abeta40 ratio correlates with impaired LTP in a mouse model of Alzheimers 
  
25
Alpha4beta2 receptor blockade causes memory impairment 
  
26
AMPA receptor downscaling in AD 
  
27
Apolipoprotein E4 (Apo E4) levels are inversely correlated with dendritic spine density 
  
28
BACE1 required for LTP at mossy fiber-CA3 synapses 
  
30
beta Amyloid increases calcium currents (2) 
  
32
Beta-amyloid blocks high frequency stimulation induced LTP but not nicotine enhanced LTP 
  
33
beta-Amyloid impairs LTP/LTD 
  
35
beta-amyloid reduces IA 
  
36
beta-Amyloid-induced depression of LTP attenuated by Verapamil 
  
37
Chronic nicotine decreases NGF and improves memory performance 
  
39
Donepezil modulates potassium channels 
  
40
Drebrin decrease in frontal cortex correlated with mild Alzheimer's disease 
  
42
Galantamine increases dopamine release in the hippocampus 
  
44
Histidine associating compounds block Abeta Channel activity and cytotoxicity 
  
47
Large decrease in spines in plaque-free regions of dentate gyrus in APP/PS1 mice 
  
48
LTP requires BDNF and is associated with cytoskeleton-associated protein 
  
50
Memory loss caused by beta-amyloid protein is rescued by a beta(3)-adrenoceptor agonist 
  
51
Model block of I_A 
  
52
Neurocortical synapse density decrease correlates with cognitive decline much more strongly than pla 
  
53
Neurofibrillary tangles are correlated with spinophilin and with Alzheimer's cognitive decline 
  
56
Nicotine desensitize alpha7 nACh receptors and facilitates LTP 
  
57
Nicotine enhances depressive actions of Abeta on LTP in rat CA1 region in vivo 
  
60
Okadaic acid mediates tau phosphorylation via L channel activation 
  
65
p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro 
  
67
Picomolar concentrations of abeta monomers disrupt LTP 
  
70
Presenilin-1 deficient neurons have increased activity of L channels 
  
72
Protofibrillar intermediates of ABeta change firing pattern of neurons. 
  
74
Regulation of back-propagating action potentials in hippocampal neurons. 
  
76
Sub-nanomolar concentrations of oligomeric beta amyloid inhibits late LTP in rats and mice 
  
78
Synaptic integration is disrupted in an AD mouse model 
  
79
The channel hypothesis of Alzheimers disease 
  



Human Brain Project Yale Center for Medical Informatics Questions, comments, problems? Email the Database Administrator
This site is Copyright 2005, Yale Center for Medical Informatics
National Institutes of Health Department of Health and Human Services